{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:38:11Z","timestamp":1791041891129,"version":"4.1.0"},"reference-count":35,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Psychiatry"],"published-print":{"date-parts":[[2018,10,1]]},"DOI":"10.1001\/jamapsychiatry.2018.1867","type":"journal-article","created":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T16:38:42Z","timestamp":1533141522000},"page":"1003","source":"Crossref","is-referenced-by-count":102,"title":["Effect of Peer Comparison Letters for High-Volume Primary Care Prescribers of Quetiapine in Older and Disabled Adults"],"prefix":"10.1001","volume":"75","author":[{"given":"Adam","family":"Sacarny","sequence":"first","affiliation":[{"name":"Department of Health Policy and Management, Mailman School of Public Health, Columbia University, New York, New York"},{"name":"Office of Evaluation Sciences, US General Services Administration, Washington, DC"},{"name":"National Bureau of Economic Research, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L.","family":"Barnett","sequence":"additional","affiliation":[{"name":"Department of Health Policy and Management, Harvard T.H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackson","family":"Le","sequence":"additional","affiliation":[{"name":"Center for Program Integrity, Centers for Medicare & Medicaid Services, US Department of Health and Human Services, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Tetkoski","sequence":"additional","affiliation":[{"name":"retired from the Center for Medicare, Centers for Medicare & Medicaid Services, US Department of Health and Human Services, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Yokum","sequence":"additional","affiliation":[{"name":"Office of Evaluation Sciences, US General Services Administration, Washington, DC"},{"name":"currently with The Lab @ DC, Government of the District of Columbia, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shantanu","family":"Agrawal","sequence":"additional","affiliation":[{"name":"Center for Program Integrity, Centers for Medicare & Medicaid Services, US Department of Health and Human Services, Baltimore, Maryland"},{"name":"currently with the National Quality Forum, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"2","key":"yoi180047r1","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/pds.v20.2","article-title":"Increasing off-label use of antipsychotic medications in the United States, 1995-2008.","volume":"20","author":"Alexander","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"8","key":"yoi180047r3","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1111\/jgs.2017.65.issue-8","article-title":"Off-label prescribing of second-generation antipsychotics to elderly veterans with posttraumatic stress disorder and dementia.","volume":"65","author":"Semla","year":"2017","journal-title":"J Am Geriatr Soc"},{"issue":"8","key":"yoi180047r4","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1176\/appi.ps.201500316","article-title":"Trends in off-label use of second-generation antipsychotics in the Medicare population from 2006 to 2012.","volume":"67","author":"Driessen","year":"2016","journal-title":"Psychiatr Serv"},{"issue":"4","key":"yoi180047r5","doi-asserted-by":"publisher","first-page":"242","DOI":"10.7326\/M13-2796","article-title":"Atypical antipsychotic drugs and the risk for acute kidney injury and other adverse outcomes in older adults: a population-based cohort study.","volume":"161","author":"Hwang","year":"2014","journal-title":"Ann Intern Med"},{"issue":"5","key":"yoi180047r6","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1001\/jamapsychiatry.2014.3018","article-title":"Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm.","volume":"72","author":"Maust","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"12","key":"yoi180047r7","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1001\/jama.2011.1360","article-title":"Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis.","volume":"306","author":"Maher","year":"2011","journal-title":"JAMA"},{"issue":"1","key":"yoi180047r8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/jcpt.2016.41.issue-1","article-title":"Quetiapine safety in older adults: a systematic literature review.","volume":"41","author":"El-Saifi","year":"2016","journal-title":"J Clin Pharm Ther"},{"issue":"9","key":"yoi180047r10","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1176\/appi.ajp.2012.12030342","article-title":"Atypical antipsychotic use in patients with dementia: managing safety concerns.","volume":"169","author":"Steinberg","year":"2012","journal-title":"Am J Psychiatry"},{"issue":"15","key":"yoi180047r11","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1001\/jama.294.15.1934","article-title":"Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials.","volume":"294","author":"Schneider","year":"2005","journal-title":"JAMA"},{"issue":"7496","key":"yoi180047r12","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1136\/bmj.38369.459988.8F","article-title":"Quetiapine and rivastigmine and cognitive decline in Alzheimer\u2019s disease: randomised double blind placebo controlled trial.","volume":"330","author":"Ballard","year":"2005","journal-title":"BMJ"},{"issue":"11","key":"yoi180047r15","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1111\/jgs.13702","article-title":"American Geriatrics Society 2015 updated Beers Criteria for potentially inappropriate medication use in older adults.","volume":"63","author":"American Geriatrics Society 2015 Beers Criteria Update Expert Panel","year":"2015","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"yoi180047r18","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1001\/jama.2012.7422","article-title":"CMS seeks to reduce antipsychotic use in nursing home residents with dementia.","volume":"308","author":"Mitka","year":"2012","journal-title":"JAMA"},{"issue":"3","key":"yoi180047r19","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1056\/NEJM199207163270306","article-title":"A randomized trial of a program to reduce the use of psychoactive drugs in nursing homes.","volume":"327","author":"Avorn","year":"1992","journal-title":"N Engl J Med"},{"issue":"5","key":"yoi180047r20","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1017\/S003329170700147X","article-title":"The DEBIT trial: an intervention to reduce antipsychotic polypharmacy prescribing in adult psychiatry wards: a cluster randomized controlled trial.","volume":"38","author":"Thompson","year":"2008","journal-title":"Psychol Med"},{"key":"yoi180047r21","first-page":"CD001175","article-title":"Computer-generated reminders delivered on paper to healthcare professionals; effects on professional practice and health care outcomes.","volume":"12","author":"Arditi","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"yoi180047r22","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1001\/jamainternmed.2013.14191","article-title":"Nudging guideline-concordant antibiotic prescribing: a randomized clinical trial.","volume":"174","author":"Meeker","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"6","key":"yoi180047r23","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1001\/jama.2016.0275","article-title":"Effect of behavioral interventions on inappropriate antibiotic prescribing among primary care practices: a randomized clinical trial.","volume":"315","author":"Meeker","year":"2016","journal-title":"JAMA"},{"issue":"10029","key":"yoi180047r24","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1016\/S0140-6736(16)00215-4","article-title":"Provision of social norm feedback to high prescribers of antibiotics in general practice: a pragmatic national randomised controlled trial.","volume":"387","author":"Hallsworth","year":"2016","journal-title":"Lancet"},{"issue":"3","key":"yoi180047r25","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1377\/hlthaff.2015.1025","article-title":"Medicare letters to curb overprescribing of controlled substances had no detectable effect on providers.","volume":"35","author":"Sacarny","year":"2016","journal-title":"Health Aff (Millwood)"},{"issue":"6","key":"yoi180047r26","first-page":"CD000259","article-title":"Audit and feedback: effects on professional practice and healthcare outcomes.","author":"Ivers","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"yoi180047r28","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jebo.2015.04.002","article-title":"Tax compliance and enforcement in the Pampas: evidence from a field experiment.","volume":"116","author":"Castro","year":"2015","journal-title":"J Econ Behav Organ"},{"issue":"3","key":"yoi180047r29","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1111\/jeea.12013","article-title":"Testing enforcement strategies in the field: threat, moral appeal and social information.","volume":"11","author":"Fellner","year":"2013","journal-title":"J Eur Econ Assoc"},{"issue":"3","key":"yoi180047r32","doi-asserted-by":"publisher","first-page":"541","DOI":"10.2307\/2530040","article-title":"Some aspects of analysis of covariance.","volume":"38","author":"Cox","year":"1982","journal-title":"Biometrics"},{"issue":"14","key":"yoi180047r34","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1001\/jama.2017.11152","article-title":"Effects of behavioral interventions on inappropriate antibiotic prescribing in primary care 12 months after stopping interventions.","volume":"318","author":"Linder","year":"2017","journal-title":"JAMA"},{"key":"yoi180047r2","volume-title":"Antipsychotic Drug Use: HHS Has Initiatives to Reduce Use Among Older Adults in Nursing Homes, but Should Expand Efforts to Other Settings","author":"Government Accountability Office (GAO)","year":"2015"},{"key":"yoi180047r9","volume-title":"Off-Label Use of Atypical Antipsychotics: An Update","author":"Maglione","year":"2011"},{"key":"yoi180047r27","volume-title":"Exploratory Data Analysis","author":"Tukey","year":"1977"},{"key":"yoi180047r30","doi-asserted-by":"crossref","DOI":"10.3386\/w18492","volume-title":"The Short-Run and Long-Run Effects of Behavioral Interventions: Experimental Evidence From Energy Conservation","author":"Allcott","year":"2012"},{"key":"yoi180047r33","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/bs.hefe.2016.10.003","volume-title":"Handbook of Economic Field Experiments","author":"Athey","year":"2017"},{"key":"yoi180047r13","unstructured":"American Psychiatric Association: Choosing Wisely. Five things physicians and patients should question. http:\/\/www.choosingwisely.org\/societies\/american-psychiatric-association\/. Released September 20, 2013; recommendation 5 updated August 21, 2014; recommendation 3 updated April 22, 2015. Accessed September 26, 2017."},{"key":"yoi180047r14","unstructured":"Seroquel (quetiapine fumarate). Highlights of prescribing information. http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2016\/020639s064lbl.pdf. Published June 2016. Accessed June 13, 2018."},{"key":"yoi180047r16","unstructured":"Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration. Pediatric postmarketing pharmacovigilance and drug utilization review: Seroquel and Seroquel XR. http:\/\/www.fda.gov\/downloads\/AdvisoryCommittees\/CommitteesMeetingMaterials\/PediatricAdvisoryCommittee\/UCM494485.pdf. Published February 19, 2016. Accessed June 13, 2018."},{"key":"yoi180047r17","unstructured":"WaltonSM, SchumockGT, LeeKV, AlexanderGC, MeltzerD, StaffordRS. Developing Evidence-Based Research Priorities for Off-Label Drug Use. Rockville, MD: Agency for Healthcare Research and Quality. Effective Health Care Research Report 12. https:\/\/effectivehealthcare.ahrq.gov\/sites\/default\/files\/pdf\/off-label-use-research-priorities_research.pdf. Published May 2009. Accessed June 13, 2018."},{"key":"yoi180047r31","unstructured":"Seroquel XR (quetiapine fumarate). Highlights of prescribing information. http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2016\/022047s038lbl.pdf. Published June 2016. Accessed June 13, 2018."},{"key":"yoi180047r35","unstructured":"Agency for Healthcare Research and Quality. Alert fatigue. https:\/\/psnet.ahrq.gov\/primers\/primer\/28\/alert-fatigue. Last updated June 2017. Accessed June 13, 2018."}],"container-title":["JAMA Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/fullarticle\/2694814","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T14:14:24Z","timestamp":1538576064000},"score":1,"resource":{"primary":{"URL":"http:\/\/archpsyc.jamanetwork.com\/article.aspx?doi=10.1001\/jamapsychiatry.2018.1867"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2018,10,1]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapsychiatry.2018.1867","relation":{},"ISSN":["2168-622X"],"issn-type":[{"value":"2168-622X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10,1]]}}}